Anixa Biosciences Inc (ANIX) - יחס שווי שוק לערך בספרים

Anixa Biosciences, Inc. (ANIX) is developing a biopharmaceutical environment to combat breast and ovarian cancers, leveraging unique patents and a partnership with the Cleveland Clinic. However, geopolitical conflicts and sanctions are hindering international trials and the delivery of biomaterials. The price trend is currently at 7.95. The investment potential remains speculative, as business success is contingent upon the results of current clinical trial stages.

This indicator reflects the market value of Anixa Biosciences, Inc. (ANIX) relative to its equity, demonstrating the premium or discount of the exchange price to net assets. By analyzing changes in the company's P/BV ratio, an investor separates speculative noise from fundamental value, which is critical for evaluating an oncology R&D brand whose assets are concentrated in intellectual property and innovative vaccines.